Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | ABBVAbbVie Inc. | JNJJohnson & Johnson |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | United States |
| Market cap | $519B | $676B |
| Price | $293.89 | $280.78 |
| Last day | +0.20% | −0.47% |
, a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV analysis and Q-Scores →Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
JNJ analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.